Financhill
Back

ProShares UltraShort QQQ Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
33

QID
ProShares UltraShort QQQ

Last Price:
$19.39
Seasonality Move:
-9.98%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$54.06
Seasonality Move:
-11.9%
Sell
33
ProShares UltraShort QQQ (QID) is a Sell

Is ProShares UltraShort QQQ a Buy, Sell or Hold?

  • The current ProShares UltraShort QQQ [QID] share price is $19.82. The Score for QID is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • QID is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QID Stock Price Chart

What is ProShares UltraShort QQQ's stock price today?

  • The ProShares UltraShort QQQ share price today is $19.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QID is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

QID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 45.3 Sell
Chaikin Money Flow: 2476081 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.61 - 20.59) Sell
Bollinger Bands (100): (19.9 - 22.72) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

QID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.88 Sell
20-day SMA: 20.15 Sell
50-day SMA: 20.33 Sell
200-day SMA: 25.58 Sell
8-day EMA: 19.86 Sell
20-day EMA: 20.06 Sell
50-day EMA: 20.5 Sell
200-day EMA: 24.93 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

ProShares UltraShort QQQ Earnings Growth & QID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

ProShares UltraShort QQQ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):